Our analysts go above and beyond to answer your specific queries. We are with you throughout the entire journey – from initial discussion to post-purchase.
As we track markets at country-level, we are able to offer hard-to-find market intelligence in both developed and emerging countries.
We believe high quality market research shouldn’t be out of reach for businesses. Our competitively-priced market research reports ensure businesses of all sizes have access to quality information
Fine needle biopsy has been used to determine palpable breast with imaging technology and also to identify non-palpable breast by use of ultrasound and stereotaxy. Certain limitations in fine needle biopsy such as lack of ability to identify between in situ and invasive cancer has made less usage of this procedure. Thus, vacuum-assisted breast biopsy systems was introduced to the market. Vacuum-assisted breast biopsy systems is a device that is being developed for the biopsy of non-palpable lesions. Vacuum-assisted breast biopsy systems has several advantages over fine needle biopsy such as it allows removal of multiple large tissue samples in a single insertion by reducing errors. Vacuum-assisted breast biopsy is a widely used procedures for patients with palpable masses of breast or breast abnormality.
The global vacuum assisted breast biopsy systems market is expected to manifest substantial growth in the market since it has proven to be effective, feasible and safe technology. Due to its minimally invasive, vacuum assisted breast biopsy systems has been widely used for removal of benign breast lesions without any severe complications. In addition to this, vacuum assisted breast biopsy systems has increased in frequency in detecting the noninvasive malignant breast lesions which as a result it has gain much popularity among the other cancer detection systems available in the market. Vacuum-assisted breast biopsy systems has the capacity of tissue acquisition in every 4.5 seconds lasting less than 30 seconds. Moreover, vacuum-assisted breast biopsy device and tubing can be disposed fully and reduces the maintenance. Apart from this, vacuum assisted breast biopsy systems is an accurate technology for the diagnosis, sampling and early identification of breast cancer which as a result, the vacuum assisted breast biopsy systems seems to have significant growth in the market. However, there occurs certain limitation of vacuum assisted breast biopsy systems. The cost of vacuum assisted breast biopsy systems is much higher than the other biopsy systems. Also, it require repeated probe insertions in every collection of samples which increases the time and the accuracy. This factor may hinder the growth of the vacuum assisted breast biopsy systems market.
The global vacuum assisted breast biopsy systems market is segmented on the basis of technology types, and end user
Geographically, vacuum assisted breast biopsy systems market is categorized into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to contribute the substantial growth in vacuum assisted breast biopsy systems market owing to advancement in technology and high adoption of new techniques. According the US Breast Cancer statics report, an estimate of 268,800 new cases is diagnosed in US in 2019. Increase in healthcare facilities and government healthcare spending, the region is likely to spur significant growth in the vacuum assisted breast biopsy systems market. Europe accounts to have considerable share in vacuum assisted breast biopsy systems due to increasing in rising aging population and increase in prevalence of the cancer. Asia Pacific has increasing potential in vacuum assisted breast biopsy systems market due to increasing demand for new technologies, rising disposable income and increasing awareness among people about vacuum assisted breast biopsy systems which as a result the overall vacuum assisted breast biopsy systems will have increase in the market. Middle East and Africa shown to have minimal growth in the market due to lack of proper healthcare infrastructure and less adoption of new technologies which may hinder the growth of the vacuum assisted breast biopsy systems market.
Some of the key players leading in vacuum assisted breast biopsy systems market are: C.R. Bard Inc, Hologic Inc., SenoRX, Inc., Medsurge Ind Private Limited, Devicor Medical Products, Inc.
The report covers exhaustive analysis on:
Regional analysis includes